PNC Financial Services Group’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$111K Sell
2,965
-838
-22% -$25.7K ﹤0.01% 2856
2026
Q1
$127K Buy
3,803
+299
+9% +$10K ﹤0.01% 2648
2025
Q4
$121K Sell
3,504
-377
-10% -$12K ﹤0.01% 2691
2025
Q3
$106K Buy
3,881
+537
+16% +$13K ﹤0.01% 2765
2025
Q2
$70.3K Buy
3,344
+940
+39% +$18K ﹤0.01% 2926
2025
Q1
$39.4K Buy
2,404
+1,546
+180% +$32.9K ﹤0.01% 3226
2024
Q4
$22.1K Buy
858
+456
+113% +$12.9K ﹤0.01% 3487
2024
Q3
$12.7K Buy
402
+343
+581% +$13K ﹤0.01% 3713
2024
Q2
$2.07K Buy
59
+33
+127% +$1.31K ﹤0.01% 4249
2024
Q1
$1.14K Buy
+26
New +$1.12K ﹤0.01% 4338

Other funds holding IDYA

PNC Financial Services Group's IDYA Position: Q2 2026 in Review

PNC Financial Services Group reduced its IDEAYA Biosciences (IDYA) stake by 22% in Q2 2026, selling an estimated $25.7K and leaving 2,965 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #2856.

PNC Financial Services Group first reported a position in IDYA in Q1 2024 and has held it in 10 quarters since. The position peaked at $127K in Q1 2026. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • PNC Financial Services Group held 2,965 shares of IDEAYA Biosciences worth $111K as of Q2 2026.
  • PNC Financial Services Group sold 838 IDEAYA Biosciences shares in Q2 2026, an estimated $25.7K.
  • IDEAYA Biosciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2856 holding.
  • PNC Financial Services Group first reported a position in IDEAYA Biosciences in Q1 2024 and has held it in 10 quarters since.
  • PNC Financial Services Group's IDEAYA Biosciences position peaked at $127K in Q1 2026.
  • 284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.